Pedro Fraiman retweeted
It was an honor to be interviewed by legendary peripheral nerve neurologist @gordonsmithMD for @ContinuumAAN audio. The episode is open access. If you see patients with peripheral neuropathy, I recommend listeningāespecially if you practice in the United States.
Listen to Drs. Gordon Smith and Marcus V. Pinto, discuss his article on "Amyloid Neuropathies" in the October #PeripheralNerve and Motor Neuron Disorders issue. Episode available on all platforms or at hubs.ly/Q04FDL1c0 @GordonSmithMD
Pedro Fraiman retweeted
ā¢Intra-expert agreement in #EEG interpretation was strong.
ā¢However, the # of flipped decisions was high enough to be clinically consequential.
ā¢We may address this āoccasion noiseā by decreasing this noise directly & reducing case ambiguity with longer & better EEG data.
Pedro Fraiman retweeted
āļø Anatomy tip: The tail of the caudate nucleus (yellow arrow)follows the C-shaped curve of the lateral ventricle. It ends near the amygdala and runs along the roof of the temporal horn of the lateral ventricle.
š” It is commonly seen on coronal T2 sequences. Do NOT mistake this for heterotopic gray matter!
#Neurology #MRI #radres #futureradres #Neurosurgery @ASNRographics @Radiopaedia #FOAMed #ENT #peds
Pedro Fraiman retweeted
Bertrand Russell on a school visit chastised a medium sized boy for ill treating a small boy.
The boy replied āthe bigs hit me so i hit the babies thats fair isnāt it?
āIn these words he had epitomised the history of the human raceā
@crystalclearjt
Pedro Fraiman retweeted
BREAKING: The average Anthropic, $ANT, employee will be worth $44 million after today's IPO, based on current indicated share price:
1. 7 Co-Founders: ~$20+ billion each
2. Several early employees: $1+ billion each
3. 598 employees: $100+ million each
4. 2,800 employees: $1+ million each
5. Total employee equity wealth: $232 billion
6. Employee stock option gains: $119 billion
San Franciscoās median single-family home sale price jumped +29% year over year to $2.39 million in October amid the IPO process.
This marks the largest jump in San Francisco's media home price since February 2018.
Thousands of new millionaires will be minted today.
Pedro Fraiman retweeted
š§ How can neurologists better recognize and manage #AutoimmuneEpilepsy?
The November issue of Practical Neurology, with Guest Medical Editor Kia Gilani, MD, explores antibody testing, GAD65-associated #epilepsy, #immunotherapy, new-onset refractory status epilepticus (#NORSE), and more.
Read the new issue today: ow.ly/NWWB5107xry
@AANmember @AmEpilepsySoc @MountSinaiNYC @EpilepsyFdn @IcahnMountSinai
Pedro Fraiman retweeted
Listen to Drs. Gordon Smith and Marcus V. Pinto, discuss his article on "Amyloid Neuropathies" in the October #PeripheralNerve and Motor Neuron Disorders issue. Episode available on all platforms or at hubs.ly/Q04FDL1c0 @GordonSmithMD
Pedro Fraiman retweeted
There are many ways to state the second law of thermodynamics. Most break down somewhere.
Conjecture Institute Senior Scientist Chiara Marlettoās constructor theory version holds at every scale, from steam engines to single atoms. It needs no approximations and has no paradox.
Pedro Fraiman retweeted
The eyes may tell you which ataxia your patient has.
This outstanding practical review reminds us that specific oculomotor findings can be powerful diagnostic clues:
-Slow saccades ā think SCA2
-Vertical supranuclear gaze palsy ā think Niemann-Pick type C
-Bilateral VOR loss ā think CANVAS
-"Bulging eyes" (pseudoproptosis) ā think SCA3
Before the genetic report arrives, the bedside eye movement exam may already be pointing you in the right direction. loom.ly/emizyAs
Pedro Fraiman retweeted
Editorial: Physical activity in ALS: friend or foe?
jnnp.bmj.com/content/early/2ā¦
Read the original research here jnnp.bmj.com/content/early/2ā¦
Pedro Fraiman retweeted
Bayes' Theorem You Can See
A probability is a share of the dots. P(A) is the part of the box covered by circle A, and P(B given A) is the part of A that is also in B: the lens divided by A.
Slide the circles around and every number updates: apart, the lens is empty and both conditionals are 0; tuck B inside A and P(A given B) becomes 1.
The lens is the same in both directions, so
P(B given A) P(A) = P(A given B) P(B)
and dividing gives Bayes' theorem:
P(B given A) = P(B) P(A given B) / P(A)
P(A given B) = P(A) P(B given A) / P(B)
The bottom box computes each one from the other side, live, and it always lands on the same number as the picture above.
Pedro Fraiman retweeted
Should Huntington's Disease Remains the First Genetic Consideration in Adults Presenting with Combined Chorea and Ataxia in Resource-Limited Settings?
@MDCP_Journal
movementdisorders.onlinelibrā¦
Pedro Fraiman retweeted
There is no such thing as safe gambling especially on the internet and advertising cues and sensitises the nucleus accumbens.
Some people are at greater risk but everyone is vulnerable to dependence and addiction
#dopaminedysregulationsyndrome
Very interesting paper!
This important paper by Mitrotti and Valente in Movement Disorders Clinical Practice resonates with me because it reminds us that the value of genetic testing is not measured by how many mutations we discover, but by how we use that information to improve patientsā lives. In Parkinsonās disease, programs such as PD GENEration have demonstrated that meaningful genetic findings are not limited to younger patients or those with a family history. As we move toward genetically targeted treatments and clinical trials involving GBA1 and LRRK2, knowing a person's genetic status may increasingly influence care, counseling, and access to research. I particularly appreciate the authorsā SMART framework: Select, Match, Assess, React, and Track. It challenges us to move beyond simply ordering tests and toward building systems that translate genetic discoveries into meaningful clinical action. However, we must also address disparities in access, genetic counseling, and the interpretation of uncertain results. Genetic testing should not become another technology available only to the privileged few. For me, the central message is simple: the future of precision medicine in Parkinsonās disease is not about testing everyone indiscriminately or testing fewer people to save money. It is about testing intelligently, ensuring equitable access, and making every result count for patients and families.
movementdisorders.onlinelibrā¦
50
Pedro Fraiman retweeted
One study. One minute. Why it matters. š§
Dr. @GLanzinoNSGY highlights a study addressing a long-standing question about whether reduced blood flow caused by severe carotid artery narrowing contributes to cognitive problems that can be reversed by reopening the artery.
Pedro Fraiman retweeted
Neural autoantibodies in the cerebrospinal fluid of individuals with schizophrenia spectrum disorders
nature.com/articles/s41467-0ā¦
Pedro Fraiman retweeted
This is a super important study for our field of #autoimmune #neurology. Patients got much better in a disease which we often find hard to treat.
Fabulous news!!
But amidst the excitement, I hear a voice of reason say:
1. No control arm
2. A short (16 week) outcome after patients were given chemotherapy and steroids
This voice of reason aims to rationalise use of a potentially toxic therapies in our patients.
My conclusion: likely to be effective - perhaps very - but we lack conventional metrics to help us determine true efficacy
š A single dose of CD19 #ChimericAntigenReceptor T-cell therapy for #StiffPersonSyndrome was associated with clinically meaningful mobility improvement and changes supportive of immune reset, with a manageable safety profile. ja.ma/48c6KTZ
Pedro Fraiman retweeted
š„Hot off the press for #ACR26 š„
The @IgG4ward foundation guidelines on the treatment of IgG4-related disease
thelancet.com/journals/lanrhā¦
Free to read on lancet.com
Pedro Fraiman retweeted
š #RIMKLA-IgG was identified as a new biomarker of paraneoplastic neurological syndrome associated with cerebellar ataxia, hindbrain encephalitis, inflammatory cerebrospinal fluid, and frequent #SmallCellLungCancer. ja.ma/4z7DjNN
Pedro Fraiman retweeted
A promising treatment for patients with SPS and other autoimmune neurological disorders. We need to better understand whether CAR-T therapy āresetsā the immune system and how long do the effects last
Stiff person syndrome (SPS) is a rare autoimmune neurologic disease that causes progressive muscle stiffness and painful spasms that can make walking, driving, working and socializing increasingly difficult.
A multicenter clinical trial evaluating chimeric antigen receptor-T cell therapy (CAR-T cell therapy) for SPS has produced promising results that are already changing lives.
Learn more: mayocl.in/4zwme1b

































